RxDoctor Payments Data

Sandra Davis, MD

Psychiatry · Fort Worth, TXNPI 1215016951

Payments from drug & device makers

$112,471in general payments, 2019–2025

Across 226 payments — averaging $497.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$96K
  • Teva Pharmaceuticals USA, Inc.$15K
  • H. Lundbeck A S$1K
  • Almatica Pharma LLC$268
  • Neurocrine Biosciences, Inc.$174
  • Biogen$88
  • plus $315 from 9 others

What the payments were for

  • Food & beverage$1,096100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$112,471 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$37,691
Medicare patients
59
Services billed
323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$110,029
TrintellixVortioxetine Hydrobromide13$13,157
Vilazodone Hcl29$2,944
Desvenlafaxine Succinate ErDesvenlafaxine Succinate29$2,524
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl17$2,449
Bupropion XlBupropion Hcl59$1,935
Quetiapine Fumarate65$1,586
Mirtazapine38$1,055
Clozapine13$998
Duloxetine Hcl62$937
Escitalopram Oxalate42$884
Buspirone Hcl48$847
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine12$837
Oxcarbazepine21$798
Trazodone Hcl59$754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$174$110,02913 claims
Almatica Pharma LLCSertraline Hcl$268$38132 claims
Lilly USA, LLCOlanzapine$18$25613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →